Covid Registry News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Covid registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Covid Registry Today - Breaking & Trending Today
Private hospital in Delhi records rise in neurological cases among post-Covid patient | Delhi News indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
TribLIVE s Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox. Neurological symptoms are frighteningly common among hospitalized covid-19 patients, and the symptoms are associated with a greater risk of death, a new study shows. A paper published Tuesday in the medical journal JAMA Network Open outlines a project studying patients from around the globe. Scientists, including several at the University of Pittsburgh, analyzed data surrounding the incidence, severity and health outcomes of covid patients who experienced a litany of neurological symptoms. “We wanted to ask this question: how many people with covid had neurological symptoms and syndromes?” said Dr. Sherry Chou, principal investigator for the study and associate professor of critical care medicine, neurology and neurosurgery at the University of Pittsburgh. “And we want to know the impact: does having neurological symptoms on top of covid impact y ....
At first glance, the results reported on Friday from the long-awaited trial of Johnson & Johnson s Covid-19 vaccine might have seemed disappointing. Its overall efficacy - the ability to prevent moderate and severe disease - was reported at 72 percent in the United States, 66 percent in Latin American countries and 57 percent in South Africa. Those figures appear far below the high bar set by Pfizer-BioNTech and Moderna, the first two vaccines authorized for emergency use in the United States, which reported overall efficacy from 94 to 95 percent. But Dr. Anthony S. Fauci, the nation s leading infectious disease expert, said that the more crucial measure was the ability to prevent severe disease, which translates to keeping people out of the hospital and preventing deaths. And that result, for Johnson & Johnson, was 85 percent in all of the countries where it was tested, including South Africa, where a rapidly spreading variant of the virus had shown some ability to elude ....
How the Search for Covid-19 Treatments Faltered While Vaccines Sped Ahead Vaccine development exceeded everyone’s expectations. But the next few months will still bring many sick people and doctors have woefully few drugs with which to treat them. A makeshift I.C.U. at a hospital in Torrance, Calif, earlier this month.Credit.Mario Tama/Getty Images Nearly a year into the coronavirus pandemic, as thousands of patients are dying every day in the United States and widespread vaccination is still months away, doctors have precious few drugs to fight the virus. A handful of therapies remdesivir, monoclonal antibodies and the steroid dexamethasone have improved the care of Covid patients, putting doctors in a better position than they were when the virus surged last spring. But these drugs are not cure-alls and they’re not for everyone, and efforts to repurpose other drugs, or discover new ones, have not had much success. ....